Page last updated: 2024-08-24

telmisartan and 8-epi-prostaglandin f2alpha

telmisartan has been researched along with 8-epi-prostaglandin f2alpha in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Böger, RH; Maas, R; Quispe-Bravo, S; Schwedhelm, E; Skamira, C	1
Böger, RH; Galle, J; Pinnetti, S; Schwedhelm, E; Wanner, C	1
Knap, N; Larczynski, W; Neuwelt, A; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L; Wozniak, M	1
Knap, N; Larczynski, W; Neuwelt, A; Petranyuk, A; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L; Wozniak, M	1

Trials

3 trial(s) available for telmisartan and 8-epi-prostaglandin f2alpha

Article	Year
Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:10 Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Arginine; Benzimidazoles; Benzoates; Blood Pressure; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Proteinuria; Renin-Angiotensin System; Telmisartan; Tetrazoles; Valine; Valsartan	2008
Spironolactone attenuates oxidative stress in patients with chronic kidney disease. Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:5 Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Benzimidazoles; Benzoates; Chronic Disease; Cilazapril; Creatinine; Cross-Over Studies; Dinoprost; Diuretics; Female; Humans; Hydrochlorothiazide; Kidney Diseases; Male; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Spironolactone; Telmisartan	2008
High-dose angiotensin-converting enzyme inhibitor attenuates oxidative stress in patients with chronic kidney disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:2 Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cilazapril; Cross-Over Studies; Dinoprost; Drug Therapy, Combination; Female; Humans; Isoprostanes; Male; Oxidative Stress; Renal Insufficiency, Chronic; Renin-Angiotensin System; Telmisartan	2009

Other Studies

1 other study(ies) available for telmisartan and 8-epi-prostaglandin f2alpha

Article	Year
ADMA and oxidative stress may relate to the progression of renal disease: rationale and design of the VIVALDI study. Vascular medicine (London, England), 2005, Volume: 10 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arginine; Benzimidazoles; Benzoates; Clinical Protocols; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Endothelium, Vascular; Humans; Hypertension; Middle Aged; Multicenter Studies as Topic; Oxidative Stress; Randomized Controlled Trials as Topic; Renal Insufficiency; Telmisartan; Tetrazoles; Valine; Valsartan	2005

Article

Year

ADMA and oxidative stress may relate to the progression of renal disease: rationale and design of the VIVALDI study.

Vascular medicine (London, England), 2005, Volume: 10 Suppl 1

Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arginine; Benzimidazoles; Benzoates; Clinical Protocols; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Endothelium, Vascular; Humans; Hypertension; Middle Aged; Multicenter Studies as Topic; Oxidative Stress; Randomized Controlled Trials as Topic; Renal Insufficiency; Telmisartan; Tetrazoles; Valine; Valsartan

2005